News

MedPage Today3h
Ozempic Shows Benefit in Type 1 Diabetes Patients With Obesity
CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...
STAT5h
Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
Amgen’s monthly obesity candidate led to substantial weight loss but a high rate of side effects and discontinuations in a ...
New health initiative to help prevent childhood obesity in Louisiana
LSU’s Pennington Biomedical Research Center is working to prevent and treat childhood obesity in the state through its Greaux ...
Nature1d
Obesity drugs show promise treating a new ailment: migraine
Head-splitting migraines could be the next ailment in a seemingly endless list that a class of blockbuster weight-loss drugs ...
Lilly Expects Orforglipron Obesity Results in Third Quarter
The Phase 3 study showed that type 2 diabetes patients taking the highest dose of daily orforglipron lost nearly 8% of their ...
Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
The New England Journal of Medicine10h
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg ...
Breakthrough drug helps rare obesity condition, but other research uncertain amid cuts
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...